Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.

Silverman DH, Mosconi L, Ercoli L, Chen W, Small GW.

Semin Nucl Med. 2008 Jul;38(4):251-61. doi: 10.1053/j.semnuclmed.2008.02.006. Review.

2.

PET imaging in the assessment of normal and impaired cognitive function.

Silverman DH, Alavi A.

Radiol Clin North Am. 2005 Jan;43(1):67-77, x. Review.

PMID:
15693648
3.

Molecular neuroimaging in degenerative dementias.

Jiménez Bonilla JF, Carril Carril JM.

Rev Esp Med Nucl Imagen Mol. 2013 Sep-Oct;32(5):301-9. doi: 10.1016/j.remn.2013.06.012. Epub 2013 Aug 9. Review. English, Spanish.

5.

Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.

Atri A.

Handb Clin Neurol. 2016;136:971-84. doi: 10.1016/B978-0-444-53486-6.00050-8. Review.

PMID:
27430453
6.

Advances in evaluation of primary brain tumors.

Chen W, Silverman DH.

Semin Nucl Med. 2008 Jul;38(4):240-50. doi: 10.1053/j.semnuclmed.2008.02.005. Review.

PMID:
18514080
7.

Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis.

Lucignani G, Perneczky R.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):399-404. doi: 10.1007/s00259-009-1361-0. Review. No abstract available.

PMID:
20033150
8.

Neuronuclear assessment of patients with epilepsy.

Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W.

Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Review.

PMID:
18514079
9.

Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders.

Seibyl JP.

Semin Nucl Med. 2008 Jul;38(4):274-86. doi: 10.1053/j.semnuclmed.2008.03.001. Review.

PMID:
18514083
10.

Brain PET in suspected dementia: patterns of altered FDG metabolism.

Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA.

Radiographics. 2014 May-Jun;34(3):684-701. doi: 10.1148/rg.343135065. Review. Erratum in: Radiographics. 2014 Jul-Aug;34(4):8A.

PMID:
24819789
11.

Current and future uses of neuroimaging for cognitively impaired patients.

Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, Kepe V, Barrio JR.

Lancet Neurol. 2008 Feb;7(2):161-72. doi: 10.1016/S1474-4422(08)70019-X. Review.

12.

PET radiotracers for molecular imaging in the brain: past, present and future.

Zimmer L, Luxen A.

Neuroimage. 2012 Jun;61(2):363-70. doi: 10.1016/j.neuroimage.2011.12.037. Epub 2011 Dec 28. Review.

PMID:
22222719
13.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

14.

Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.

Calabria FF, Calabria E, Gangemi V, Cascini GL.

Hell J Nucl Med. 2016 Jan-Apr;19(1):33-41. doi: 10.1967/s002449910335. Epub 2016 Mar 1. Review.

15.

Positron emission tomography imaging in dementia.

Herholz K, Carter SF, Jones M.

Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129. Review.

PMID:
18445746
16.

Target-specific PET probes for neurodegenerative disorders related to dementia.

Kadir A, Nordberg A.

J Nucl Med. 2010 Sep;51(9):1418-30. doi: 10.2967/jnumed.110.077164. Review.

17.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
18.

Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.

Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S.

Curr Alzheimer Res. 2009 Jun;6(3):312-9. Review.

PMID:
19519314
19.

Guidance for reading FDG PET scans in dementia patients.

Herholz K.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):332-43. Epub 2014 Nov 13. Review.

20.

Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.

Rinne JO, Någren K.

J Alzheimers Dis. 2010;19(1):291-300. doi: 10.3233/JAD-2010-1224. Review.

PMID:
20061645

Supplemental Content

Support Center